The obtained results confirmed our hypothesis that ALS progression modulates the insulin/Akt/FOXO3a pathway, resulting in muscle atrophy, and that swim training partially reduces the aberrant activation of this pathway, with a concomitant amelioration of skeletal muscle mass atrophy. The gene discussed is FOXO3; the disease is amyotrophic lateral sclerosis.